Stock TMBRQ TREX WIND-DOWN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Trex Wind-down, Inc.

Equities

TMBRQ

US8870802084

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 12:12:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.0002 USD 0.00% Intraday chart for Trex Wind-down, Inc. +100.00% -83.33%
Apr. 04 First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc. CI
Mar. 20 Second Revised Disclosure Statement and Plan Approved on Interim Basis for Timber Pharmaceuticals, Inc. CI

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 8.94 24.24 5.2
Enterprise Value (EV) 1 -0.5738 10.19 -3.549
P/E ratio -0.76 x -1.43 x -0.19 x
Yield - - -
Capitalization / Revenue 19.7 x 27.3 x 62.5 x
EV / Revenue -1.26 x 11.5 x -42.7 x
EV / EBITDA - -957,018 x 184,556 x
EV / FCF 50,854 x -2,010,994 x 427,015 x
FCF Yield 0% -0% 0%
Price to Book 2.65 x 1.82 x 0.99 x
Nbr of stocks (in thousands) 241 1,276 2,971
Reference price 2 37.15 19.00 1.750
Announcement Date 3/23/21 3/31/22 3/31/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales 1 0.3246 0.4538 0.8865 0.0832
EBITDA - - -10.65 -19.23
EBIT 1 -3.645 -18.71 -10.65 -19.24
Operating Margin -1,122.63% -4,123.03% -1,201.33% -23,125.86%
Earnings before Tax (EBT) 1 -3.645 -15.08 -10.67 -19.37
Net income 1 -3.645 -15.12 -10.64 -19.38
Net margin -1,122.68% -3,331.27% -1,200.09% -23,299.05%
EPS - -48.60 -13.31 -9.193
Free Cash Flow - -11.28 -5.068 -8.312
FCF margin - -2,486.28% -571.63% -9,992.88%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 3/30/20 3/23/21 3/31/22 3/31/23
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales 1 0.19 0.0832 - - - - -
EBITDA - - - - - - -
EBIT 1 -2.805 -3.138 -9.404 -3.127 -3.566 -4 -3.999
Operating Margin -1,476.18% -3,772.76% - - - - -
Earnings before Tax (EBT) - - - - - - -
Net income - - - - - - -
Net margin - - - - - - -
EPS - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 3/31/22 5/12/22 8/11/22 11/14/22 3/31/23 5/15/23 8/21/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 - - - -
Net Cash position 1 0.06 9.51 14.1 8.75
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - -11.3 -5.07 -8.31
ROE (net income / shareholders' equity) - -371% -93.4% -209%
ROA (Net income/ Total Assets) - -200% -45.1% -85.3%
Assets 1 - 7.574 23.6 22.71
Book Value Per Share - 14.00 10.40 1.760
Cash Flow per Share - 19.10 13.20 3.060
Capex - - 0.02 0.01
Capex / Sales - - 2.01% 8.52%
Announcement Date 3/30/20 3/23/21 3/31/22 3/31/23
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
TREX WIND-DOWN, INC. Stock Trex Wind-down, Inc.
-83.33% 617
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.77% 42.86B
LONZA GROUP AG Stock Lonza Group AG
+45.32% 41.36B
MODERNA, INC. Stock Moderna, Inc.
+12.24% 42.74B
CELLTRION, INC. Stock Celltrion, Inc.
-8.83% 27.68B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+7.44% 25.15B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.01% 18.63B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.56% 12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.82% 11.92B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+8.35% 11.21B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. TMBRQ Stock
  4. Financials Trex Wind-down, Inc.